SYBU: A Protein with Potential as A Drug Target Or Biomarker (G55638)

Target Name: SYBU

NCBI ID: G55638

SYBU

SYBU: A Protein with Potential as A Drug Target Or Biomarker

Syntaphilin-like, also known as SYBU, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells.

SYBU has been shown to play a role in a variety of physiological processes in the body, including the regulation of cell growth, the development and maintenance of tissues, and the response to stimuli. It is also involved in the regulation of ion and water balance in the body, which is important for maintaining the stability of cellular homeostasis.

One of the unique features of SYBU is its ability to interact with a variety of different proteins, including those involved in the regulation of cell growth and differentiation. This suggests that SYBU may be a useful drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

SYBU has also been shown to play a role in the development and progression of a variety of diseases, including cancer. For example, studies have shown that high levels of SYBU are associated with the development of cancer, and that inhibiting SYBU signaling may be a useful strategy for cancer treatment.

In addition to its potential as a drug target or biomarker, SYBU is also of interest as a potential therapeutic agent for a variety of diseases. For example, because SYBU is involved in the regulation of cell growth and differentiation, it may be useful for treating diseases that are characterized by uncontrolled cell growth, such as cancer.

In addition, SYBU may also be useful for treating other diseases that are characterized by inflammation or cellular imbalance, such as autoimmune diseases or chronic inflammatory conditions. This is because SYBU has been shown to play a role in the regulation of the immune response, and may be able to modulate the activity of immune cells to improve their targeting of foreign particles orto maintain cellular homeostasis.

Overall, SYBU is a protein that has significant potential as a drug target or biomarker for a variety of diseases. Its ability to interact with a variety of different proteins, including those involved in the regulation of cell growth and differentiation, makes it an attractive target for the development of new therapeutic agents. Additionally, its role in the regulation of cell growth and differentiation, as well as its potential as a therapeutic agent for a variety of diseases, makes it an important molecule to study further.

Protein Name: Syntabulin

Functions: Part of a kinesin motor-adapter complex that is critical for the anterograde axonal transport of active zone components and contributes to activity-dependent presynaptic assembly during neuronal development

The "SYBU Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYBU comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets